Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell Lymphomas
接受商业化 Axicabtagene Ciloleucel 和 Tisagenlecleucel 治疗复发/难治性侵袭性 B 细胞淋巴瘤患者的用药模式、疗效和资源利用情况
期刊:Transplantation and Cellular Therapy
影响因子:4.4
doi:10.1016/j.jtct.2022.07.011
Riedell, Peter A; Hwang, Wei-Ting; Nastoupil, Loretta J; Pennisi, Martina; McGuirk, Joseph P; Maziarz, Richard T; Bachanova, Veronika; Oluwole, Olalekan O; Brower, Jamie; Flores, Oscar A; Ahmed, Nausheen; Schachter, Levanto; Bharucha, Kharmen; Dholaria, Bhagirathbhai R; Schuster, Stephen J; Perales, Miguel-Angel; Bishop, Michael R; Porter, David L